{"nct_id":"NCT02379390","title":"Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide","status":"TERMINATED","status_verified_date":"2019-06","start_date":"2015-06-17","start_date_type":"ACTUAL","primary_completion_date":"2018-05-10","primary_completion_date_type":"ACTUAL","completion_date":"2018-05-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}